Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Northcott

Showing results (211-220 of 223) with videos related to

Pageof 23
Sort By:
The Lancet. Oncology|May 14, 2018
Spectrum and prevalence of genetic predisposition in medulloblastoma: a retrospective genetic study and prospective validation in a clinical trial cohortSebastian M Waszak, Paul A Northcott, Ivo Buchhalter, et al.
Nature|July 21, 2017
The whole-genome landscape of medulloblastoma subtypesPaul A Northcott, Ivo Buchhalter, A Sorana Morrissy, et al.
Nature|July 27, 2012
Dissecting the genomic complexity underlying medulloblastomaDavid T W Jones, Natalie Jäger, Marcel Kool, et al.
Acta Neuropathologica|November 1, 2013
TERT promoter mutations are highly recurrent in SHH subgroup medulloblastomaMarc Remke, Vijay Ramaswamy, John Peacock, et al.
Nature|February 21, 2014
Epigenomic alterations define lethal CIMP-positive ependymomas of infancyS C Mack, H Witt, R M Piro, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 5, 2014
Cytogenetic prognostication within medulloblastoma subgroupsDavid J H Shih, Paul A Northcott, Marc Remke, et al.
Cell|February 27, 2016
New Brain Tumor Entities Emerge from Molecular Classification of CNS-PNETsDominik Sturm, Brent A Orr, Umut H Toprak, et al.
The Lancet. Oncology|March 16, 2016
Prognostic value of medulloblastoma extent of resection after accounting for molecular subgroup: a retrospective integrated clinical and molecular analysisEric M Thompson, Thomas Hielscher, Eric Bouffet, et al.
Cancer Cell|December 5, 2025
Advancing CNS tumor diagnostics with expanded DNA methylation-based classificationMartin Sill, Daniel Schrimpf, Areeba Patel, et al.
Medrxiv : the Preprint Server for Health Sciences|June 10, 2025
Advancing CNS tumor diagnostics with expanded DNA methylation-based classificationMartin Sill, Daniel Schrimpf, Areeba Patel, et al.
Pageof 23

Showing results (211-220 of 223) with videos related to

Sort By:
Pageof 23
The Lancet. Oncology|May 14, 2018
Spectrum and prevalence of genetic predisposition in medulloblastoma: a retrospective genetic study and prospective validation in a clinical trial cohortSebastian M Waszak, Paul A Northcott, Ivo Buchhalter, et al.
Nature|July 21, 2017
The whole-genome landscape of medulloblastoma subtypesPaul A Northcott, Ivo Buchhalter, A Sorana Morrissy, et al.
Nature|July 27, 2012
Dissecting the genomic complexity underlying medulloblastomaDavid T W Jones, Natalie Jäger, Marcel Kool, et al.
Acta Neuropathologica|November 1, 2013
TERT promoter mutations are highly recurrent in SHH subgroup medulloblastomaMarc Remke, Vijay Ramaswamy, John Peacock, et al.
Nature|February 21, 2014
Epigenomic alterations define lethal CIMP-positive ependymomas of infancyS C Mack, H Witt, R M Piro, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 5, 2014
Cytogenetic prognostication within medulloblastoma subgroupsDavid J H Shih, Paul A Northcott, Marc Remke, et al.
Cell|February 27, 2016
New Brain Tumor Entities Emerge from Molecular Classification of CNS-PNETsDominik Sturm, Brent A Orr, Umut H Toprak, et al.
The Lancet. Oncology|March 16, 2016
Prognostic value of medulloblastoma extent of resection after accounting for molecular subgroup: a retrospective integrated clinical and molecular analysisEric M Thompson, Thomas Hielscher, Eric Bouffet, et al.
Cancer Cell|December 5, 2025
Advancing CNS tumor diagnostics with expanded DNA methylation-based classificationMartin Sill, Daniel Schrimpf, Areeba Patel, et al.
Medrxiv : the Preprint Server for Health Sciences|June 10, 2025
Advancing CNS tumor diagnostics with expanded DNA methylation-based classificationMartin Sill, Daniel Schrimpf, Areeba Patel, et al.
Pageof 23